RSS
RSV
Sanofi Pasteur and MedImmune collaborate on monoclonal antibody to prevent illnesses associated with RSV
Sanofi and Sanofi Pasteur have announced an agreement with MedImmune to develop and commercialise a monoclonal antibody for the prevention of Respiratory Syncytial Virus (RSV). Read more
